ACTIVE SUBSTANCE / INN

DIATRIZOATE MEGLUMINE

Brand name(s): ANGIOVIST 282, HYPAQUE-M,90%, CARDIOGRAFIN, UROVIST CYSTO, HYPAQUE-M,75%, MD-76, UROVIST CYSTO PEDIATRIC, DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM, ANGIOVIST 292, UROVIST MEGLUMINE DIU/CT
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA087724
ANDA087731
ACTIVE SUBSTANCE
Diatrizoate Meglumine
REGULATORS
FDA
SPONSORS / MAH
MALLINCKRODT, BRACCO, ANDA REPOSITORY
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
MD-76ANDA087073MALLINCKRODTDiscontinued
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUMANDA214201ANDA REPOSITORYPrescription
ANGIOVIST 282ANDA087726BAYER HLTHCAREDiscontinued
UROVIST CYSTOANDA087729BAYER HLTHCAREDiscontinued
UROVIST CYSTO PEDIATRICANDA087731BAYER HLTHCAREDiscontinued
UROVIST MEGLUMINE DIU/CTANDA087739BAYER HLTHCAREDiscontinued
CARDIOGRAFINNDA011620BRACCODiscontinued
ANGIOVIST 292ANDA087724BAYER HLTHCAREDiscontinued
HYPAQUE-M,90%NDA010220GE HEALTHCAREDiscontinued
HYPAQUE-M,75%NDA010220GE HEALTHCAREDiscontinued

FULL INTELLIGENCE ON DIATRIZOATE MEGLUMINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →